@techcrunch.com 2 years ago
Journey Clinical raises $3M to allow psychotherapists to prescribe psychedelics
@techcrunch.com 2 years ago
Rani Therapeutics’ $73M IPO will fund upcoming clinical trials
@xconomy.com 3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com 3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com 3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com 3 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com 5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@techcrunch.com 5 years ago
Public shareholders got high today on Tilray, the first marijuana company to IPO on Nasdaq
@xconomy.com 5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M